secwatch.observer — SEC 8-K summary
======================================

Issuer:     Core Laboratories Inc. /DE/ (CLB)
CIK:        0001958086
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0000950170-24-116676
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Core Lab Q3 revenue $134.4M +7% YoY; EPS ex-items $0.25 +14% YoY; net debt reduced
--------------------------------------------------------------------------------

- Revenue $134.4M, up 3% sequentially and over 7% year-over-year.
- Operating income ex-items $18.2M, up 11% sequentially and 14% YoY; margins 14%.
- GAAP EPS $0.25; ex-items $0.25, up 14% sequentially and YoY.
- Free cash flow $10.4M; net debt reduced $11.8M; debt leverage ratio 1.47.
- Declares Q4 dividend $0.01/share, payable Nov 25 to holders of record Nov 4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024116676/0000950170-24-116676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024116676/clb-20241023.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-116676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer